Mayo Clinic Talks Episode 57: Benefits and Risks of Hormone Therapy in Women
Mayo Clinic Talks Podcast
|For years, healthcare providers routinely prescribed hormone therapy for the management of women with postmenopausal symptoms as well as to reduce the risk of cardiovascular disease and the treat osteoporosis. Then, in 2002, the Women’s Health Initiative was published and our views of hormone therapy changed. Parts of the study’s findings were criticized leading to confusion as to whether hormone therapy was as effective as we assumed as well as whether hormone therapy was exposing women to excessive health risks. To help us sort out the benefits and risks of hormone therapy in women, we’re joined by Dr. Ekta Kapoor, a Mayo Clinic internist and specialist in the Menopause and Women’s Sexual Health Clinic.|
This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants
Upon completion of the Mayo Clinic Talks Podcast course, learners should be able to:
- Describe the current treatment recommendations for patients with hyperlipidemia.
- List the various categories of hypertension.
- Describe the current pharmacologic treatment available for patients with osteoporosis.
Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Attendance